Latest News
Edgewise Therapeutics, Inc.
- What Edgewise Therapeutics Stock's HFpEF Trial Start Means For Shareholders
- William Blar Initiates Coverage on Edgewise Therapeutics With Outperform Rating
- William Blair initiates Edgewise Therapeutics stock with outperform rating
- Edgewise Therapeutics initiated with an Outperform at William Blair
- Is Edgewise Therapeutics (EWTX) Undervalued As Its HFpEF Phase 2 Trial Begins?
- Edgewise Therapeutics (EWTX) Rises 3.51% to $38.32 as Buyers Step Back In - ETH Profile
- H.C. Wainwright reiterates Edgewise Therapeutics stock rating at buy
- Edgewise Therapeutics, Inc. Share Price Live Today – NASDAQ:EWTX Stock Price, Chart, News, History
- Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)
- Edgewise Therapeutics starts Phase 2 trial of E...
Headlines from the last 30 days, linking to the original publishers. See all market news →